Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
PaperCitations, authors & open-access status
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,721 citations, 2017 year and green oa status.
1,721
Citations
2017
Year
green
OA Status